Alexander Labrunerie & Co’s Amgen AMGN Stock Holding History

Alexander Labrunerie & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$268K	Sell	741 -130	-15%	-$44.5K	0.09%	98
2026 Q1	$306K	Hold	871	–	–	0.11%	92
2025 Q4	$285K	Hold	871	–	–	0.1%	92
2025 Q3	$246K	Sell	871 -15	-2%	-$4.35K	0.09%	94
2025 Q2	$247K	Sell	886 -73	-8%	-$20.7K	0.1%	94
2025 Q1	$299K	Buy	959 +21	+2%	+$6.2K	0.13%	82
2024 Q4	$244K	Sell	938 -34	-3%	-$10.1K	0.11%	89
2024 Q3	$313K	Sell	972 -30	-3%	-$9.81K	0.14%	76
2024 Q2	$313K	Buy	1,002 +74	+8%	+$21.7K	0.17%	66
2024 Q1	$264K	Buy	+928	New	+$272K	0.15%	74

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Alexander Labrunerie & Co's AMGN Position: Q2 2026 in Review

Alexander Labrunerie & Co reduced its Amgen (AMGN) stake by 15% in Q2 2026, selling an estimated $44.5K and leaving 741 shares worth $268K. The position accounts for 0.09% of the portfolio, ranked #98.

Alexander Labrunerie & Co first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $313K in Q3 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Alexander Labrunerie & Co held 741 shares of Amgen worth $268K as of Q2 2026.
Alexander Labrunerie & Co sold 130 Amgen shares in Q2 2026, an estimated $44.5K.
Amgen made up 0.09% of Alexander Labrunerie & Co's portfolio in Q2 2026, its #98 holding.
Alexander Labrunerie & Co first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
Alexander Labrunerie & Co's Amgen position peaked at $313K in Q3 2024.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Alexander Labrunerie & Co's 13F filing for Q2 2026, filed 3 Aug 2026.